According to research reviewed by Gram, a synbiotic blend (a mix of probiotics and prebiotic fiber) lowered LDL cholesterol and liver fat in high-fat-fed mice over four weeks. Treated mice showed a complete absence of aortic inflammation, unlike untreated mice on the same diet. These results come from animal experiments and have not yet been tested in people.
Gram Research analysis of a 2026 study in Probiotics and Antimicrobial Proteins looked at whether a mix of helpful gut bacteria and the fiber they feed on could protect against heart problems caused by a high-fat diet. Researchers fed genetically altered mice, which tend to develop clogged arteries, a fatty diet for four weeks. Some mice also received a synbiotic supplement, a combination of probiotics and prebiotic fiber. The treated mice had lower LDL cholesterol and less fat building up in their livers. Their gut bacteria stayed more balanced, they produced more butyrate, a helpful compound made by gut microbes, and their arteries showed no signs of inflammation. Because this was an animal study, the results point to a promising direction but do not yet show the same effects in people.
Key Statistics
A 2026 mouse study published in Probiotics and Antimicrobial Proteins found that a synbiotic supplement lowered LDL cholesterol and liver fat in high-fat-fed mice over four weeks.
In the same 2026 mouse study, synbiotic-treated mice showed a complete absence of aortic inflammation, while untreated mice on the high-fat diet showed inflammation in the aorta.
The 2026 study reported that synbiotic treatment significantly increased fecal butyrate, a fatty acid produced by gut bacteria, in mice fed a high-fat diet for four weeks.
The Quick Take
- What they studied: Researchers wanted to know whether a supplement combining probiotics (beneficial live bacteria) and prebiotics (fiber that feeds those bacteria) could counter the heart and metabolic damage caused by a high-fat diet.
- Who participated: The study used mice that were bred to lack a protein called ApoE, which helps clear cholesterol from the blood, so they develop clogged arteries easily. The exact number of mice was not specified in the report. All of the participants were animals, not people.
- Key finding: Mice given the supplement had lower LDL (bad) cholesterol, less fat in the liver, more butyrate in their stool, and a complete absence of aortic inflammation, while untreated mice on the same high-fat diet showed inflammation in their aorta, the main artery leaving the heart. The report gives these as clear group differences but does not list exact percentages in the summary.
- What it means for you: These results do not yet tell people what to take. They do suggest that gut health may be linked to cholesterol and artery health, which is worth discussing with a doctor, especially if you have high cholesterol or a family history of heart disease.
The Research Details
The researchers used a laboratory experiment with mice that were genetically changed so they could not properly clear cholesterol from their blood. This type of mouse is widely used to study heart disease because it develops clogged arteries much faster than typical mice. All of the mice were fed a high-fat diet for four weeks. One group received a plain placebo, which is a substance with no active ingredient, while another group received the synbiotic supplement.
After the four weeks, the team measured blood cholesterol, fat in the liver, and the activity of genes involved in cholesterol handling in both the liver and the small intestine. They also used a lab technique called flow cytometry to count and sort immune cells in the lymph nodes and spleen. To study the gut, they used shotgun sequencing, which reads the genetic material of all the bacteria in a stool sample to identify which microbes are present. They also measured short-chain fatty acids, which are compounds made when gut bacteria break down fiber.
The design lets scientists control almost everything about the mice, including their diet, genetics, and environment. This makes it possible to test cause and effect in a way that is not practical in people. However, because the mice are not humans, the results show what might happen, not what will happen, in human bodies.
Controlled animal studies are an important early step in drug and supplement research. By comparing treated mice with untreated mice on the same diet and genetic background, researchers can see whether the supplement itself causes the changes. Measuring many things at once, from blood cholesterol to immune cells to gut bacteria, helps show the pathways that might connect gut health to heart health.
This approach also helps identify promising ideas that deserve further study. Human trials would still be needed to confirm safety, the right dose, and whether the same benefits occur in people who eat high-fat diets.
The study used a comparison group and measured many outcomes with established laboratory methods, which strengthens confidence in the basic findings. The journal is a peer-reviewed publication in the field of microbiology and immunology, so the work went through expert review before publication.
However, the report does not state the number of mice in each group, which makes it harder to judge how strong the statistics are. Animal studies also tend to be small and short, and results often do not carry over fully to people. Readers should treat the findings as early evidence rather than proof.
What the Results Show
The main finding was that the synbiotic supplement lowered LDL cholesterol in the blood of high-fat-fed mice. LDL is often called bad cholesterol because high levels can build up in artery walls over time. The treated mice also had significantly less fat accumulating in their livers, a condition linked to metabolic problems in people. Importantly, their body weight and organ weights did not change, which suggests the effect was not simply due to weight loss.
The supplement also appeared to restore healthier cholesterol handling in the intestine. In mice on the high-fat diet, the genes that control how cholesterol is processed were disrupted. The supplement reduced this disruption, and the liver cholesterol levels in treated mice were similar to those of mice eating a regular diet.
The gut microbiome, the community of bacteria living in the intestines, also shifted in a helpful direction. The high-fat diet caused an imbalance, but the supplement preserved bacteria known to produce short-chain fatty acids, including Lactobacillus johnsonii, Bacteroides fragilis, and Eubacterium species. Fecal butyrate, a fatty acid that supports the gut lining and has anti-inflammatory effects, was significantly higher in treated mice.
The most striking result concerned the arteries. Untreated mice on the high-fat diet showed inflammation in the aorta, while treated mice showed no signs of aortic inflammation at all. Immune changes were also observed, with fewer Th17 cells, a type of immune cell linked to inflammation, in the lymph nodes, and more cytotoxic T cells in the spleen.
Beyond the main measurements, the researchers reported that the supplement appeared to reprogram parts of the immune system. Reduced Th17 cells in the lymph nodes may indicate less background inflammation, which is important because chronic inflammation is thought to contribute to artery damage. The rise in cytotoxic T cells in the spleen suggests a shift in immune activity, though its exact meaning for heart health is still unclear.
The increase in butyrate is also significant. Butyrate is produced when gut bacteria ferment fiber, and it is known to help maintain the intestinal lining and calm inflammation in laboratory studies. Its rise suggests the supplement may be working partly through the metabolites that gut bacteria produce, not only through the bacteria themselves.
Earlier research has linked gut bacteria to cholesterol metabolism and inflammation, and several animal studies have found that probiotics or fiber can lower blood cholesterol. This study adds to that work by combining both approaches and measuring the effects on the artery, not just on blood levels. Gram Research analysis places this study within a growing body of work suggesting that the gut-heart connection is a real area of interest.
Still, results from mouse studies have a mixed track record in human trials. Many compounds that look promising in mice have not produced the same benefits in people, so this study should be seen as a starting point for further research rather than a conclusion.
The most important limitation is that the study was done in mice, not people. Mice metabolize food, process cholesterol, and handle gut bacteria differently from humans. The mice also had a genetic change that makes them prone to heart disease, so the results may not apply to people with other causes of heart problems.
The study was relatively short, lasting four weeks, so it is not clear whether the benefits would last over months or years. The report also did not specify the number of mice in each group, which limits how confidently the statistical results can be judged. Finally, because the supplement was tested as a specific formulation, its effects may not match those of other probiotic or fiber products.
The Bottom Line
Confidence is currently low for applying these findings directly to people. The study offers early evidence that a combined probiotic and prebiotic supplement may lower LDL cholesterol, reduce liver fat, and support healthier gut bacteria in mice. Human research is needed before any recommendation can be made for people with high cholesterol.
For general readers, the more established steps remain the most reliable: eating more fiber from vegetables, fruits, beans, and whole grains, limiting saturated fat, and following guidance from a healthcare provider on cholesterol management. Anyone considering a probiotic or prebiotic supplement should check with a doctor first, particularly if they take medications.
People with high cholesterol, fatty liver disease, or a family history of heart disease may find this research interesting, and it is worth discussing with a doctor. Researchers and supplement developers working on gut-based approaches to heart health will find the findings especially relevant.
This research is less directly relevant to people who already have well-controlled cholesterol through medication and lifestyle changes, and it should not change treatment plans for anyone without medical advice. Children, pregnant people, and people with weakened immune systems should be especially cautious about any supplement use without professional guidance.
Because this study ran for four weeks in mice, it does not provide a timeline for people. Human studies on similar approaches typically run for several months to measure changes in blood cholesterol and artery health. Changes in gut bacteria can begin within days to weeks of changing diet or supplements, but changes in cholesterol and heart markers usually take longer to show up in blood tests, often two to three months or more.
Frequently Asked Questions
Can probiotics and prebiotics lower cholesterol?
A 2026 mouse study found that a combined probiotic and prebiotic supplement lowered LDL cholesterol and liver fat in high-fat-fed mice over four weeks. Results in people have not yet been confirmed, so anyone with high cholesterol should consult a doctor before making changes.
What is a synbiotic supplement?
A synbiotic is a supplement that combines probiotics, which are live beneficial bacteria, with prebiotics, which are fibers that feed those bacteria. In the 2026 mouse study, the combination helped preserve helpful gut bacteria and increased butyrate, a compound that supports the gut lining.
Does gut health affect artery health?
Research reviewed by Gram suggests gut bacteria may influence cholesterol processing and inflammation that affect arteries. In a 2026 mouse study, treated animals showed no aortic inflammation, while untreated mice on a high-fat diet did. More human research is needed to confirm this link.
Should I take a probiotic to lower my cholesterol?
Current evidence from this study comes only from mice, so it cannot support a recommendation for people. Proven steps include eating more soluble fiber, limiting saturated fat, and following a healthcare provider’s cholesterol plan. Ask a doctor before starting any supplement, especially if you take medication.
Want to Apply This Research?
- Track daily fiber intake in grams, along with the number of servings of fruits, vegetables, and whole grains eaten each day. Log any probiotic or prebiotic supplement use, including the product name and dose. Record bowel regularity on a simple 1 to 5 scale each day to see patterns over time.
- Set a weekly goal of adding one high-fiber food, such as oats, lentils, chia seeds, or a vegetable side dish, to meals. Use the app to remind you to hit a daily fiber target and to note which foods make you feel fuller or more comfortable. If you are discussing supplements with a doctor, bring your logged data to the appointment.
- Review fiber intake and bowel patterns weekly and look for trends over three months. If you have had blood cholesterol tests, add those results to the app so you can compare them with your eating and supplement habits over time. Share the log with your healthcare provider at regular checkups to guide decisions, rather than relying on the app alone.
This article summarizes a study conducted in mice, and its findings may not apply to humans. It is for educational purposes only and is not medical advice. Do not start, stop, or change any supplement, medication, or diet based on this information without consulting a qualified healthcare provider, especially if you have heart disease, high cholesterol, or other medical conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.